La chaîne d'options affiche les données clés des options sur actions de PepGen à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour PepGen..

PepGen (NASDAQ:PEPG) Stock, Chaîne d'Options

PEPGEN INC

PepGen

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

PepGen Inc

Press Releases

PepGen Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 8, 2025 to Discuss Your Rights - PEPG

News

Legal

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of PepGen Inc.(PEPG) Shareholders

Faruqi & Faruqi Reminds PepGen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - PEPG

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Kuehn Law Encourages Investors of PepGen Inc. to Contact Law Firm

PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients

PepGen Announces Proposed Public Offering

PepGen Announces Pricing of $100 Million Public Offering

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

PEPG

AC Immune

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Altimmune

Amarin Corporation plc - American Depositary Shares

Amarin Corp

Annexon

Avalo Therapeutics

Candel Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

DiaMedica Therapeutics Inc. - Common Stock

DiaMedica Therapeutics

Design Therapeutics

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

ETHZilla

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics

Humacyte

Immutep Limited - American Depositary Shares

Immutep

Korro Bio

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Lineage Cell Therapeutics, Inc. Common Stock

Lineage Cell Therapeutics

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Lyell Immunopharma

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

ProQR Therapeutics N.V. - Ordinary Shares

ProQR Therapeutics

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Vanda Pharmaceuticals Inc. - Common Stock

Comments

PepGen

PepGen (PEPG) Options

PepGen (NASDAQ:PEPG) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL